Early Ki67 change predicts prognosis and supports response-adapted therapy in breast cancer treated with neoadjuvant chemotherapy

Background: Early prediction of response to neoadjuvant chemotherapy (NACT) in breast cancer is critical for optimizing treatment strategies and improving outcomes. This study assessed the prognostic value of early Ki67 change (ΔKi67 %) via on-treatment core needle biopsy (CNB) in stratifying event-...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Ying Zhang, Siyu Wu, Liang Xue, Yifan Xie, Juping Shen, Zhimin Shao, Guangyu Liu
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2026-02-01
Serija:	Breast
Teme:	Breast cancer Neoadjuvant chemotherapy Ki67 Event-free survival On-treatment biopsy
Online dostop:	http://www.sciencedirect.com/science/article/pii/S0960977625008665
Oznake:	Označite Brez oznak, prvi označite!